Has spent career working on biomarkers of cardiac injury, thrombosis and hemodynamic stress. For that reason, he has been involved in most of the major guideline initiatives in defining myocardial injury and myocardial infarction. He has published original research extensively and is a member of most of the major editorial boards.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease